Skip to content
10-Q

Quarterly Report

GREENWICH LIFESCIENCES, INC. GLSI

0001641172-25-011731

← back to feed
Filed
May 20, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 9, 2025 13.37M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $2.75M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $4.09M
Current Liabilities Q1 2025 · Mar 31, 2025 $1.44M
Current Liabilities Q1 2025 · Dec 31, 2024 $1.56M
Total Liabilities Q1 2025 · Mar 31, 2025 $1.44M
Total Liabilities Q1 2025 · Dec 31, 2024 $1.56M
Total Assets Q1 2025 · Mar 31, 2025 $2.75M
Total Assets Q1 2025 · Dec 31, 2024 $4.09M
Shares Diluted Q1 2025 · Mar 31, 2024 12.86M sh
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$1.78M
Stockholders Equity Q1 2025 · Mar 31, 2024 $5.12M
Stockholders Equity Q1 2025 · Dec 31, 2023 $6.7M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.19
Eps Basic Q1 2025 · Mar 31, 2024 −$0.19
Sga Expense Q1 2025 · Mar 31, 2024 $342.69K
Rd Expense Q1 2025 · Mar 31, 2024 $2.19M
Net Income Q1 2025 · Mar 31, 2024 −$2.47M
Operating Income Q1 2025 · Mar 31, 2024 −$2.54M